4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-059988
Chief Executive Officer bought 6,440 shares at $4.68 ($30,139)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2017-11-08 | Purchase | +6,440 | $4.68 | $30,139 | 1,083,731 | D |
| Open-market purchases · 6,440 sh · avg $4.68 · $30,139 | |||||||
Loading xslF345X03/doc4.xml…